Journal of Urologic Oncology

Most read articles

Page Path

HOME
BROWSE ARTICLES
Most read articles

From articles published in J Urol Oncol during the past two years (2023~ ).

Review Article

Complex Epidemiology of Prostate Cancer in Asian Countries (7,510 times): Kagenori Ito, Takahiro Kimura; Journal of Urologic Oncology. 2023;21(1):5-13. Published online March 31, 2023; DOI: https://doi.org/10.22465/juo.234600140007
Cited By 11; Full text PubReader ePub PDF

Optimal Management for BCG Unresponsive Non-Muscle-Invasive Bladder Cancer

Invited Review

Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023 (5,560 times): Jiwoong Yu, Hyun Hwan Sung; Journal of Urologic Oncology. 2023;21(3):228-240. Published online November 30, 2023; DOI: https://doi.org/10.22465/juo.234600420021
Cited By 2; Full text PubReader ePub PDF

Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma

Invited Review

Role of Radiotherapy in Metastatic Renal Cell Carcinomas: An Evolutionary Journey in a Misunderstood Histological Type (5,091 times): Chan Woo Wee, Jaeho Cho; Journal of Urologic Oncology. 2023;21(3):217-227. Published online November 30, 2023; DOI: https://doi.org/10.22465/juo.234600560028
Cited By 2; Full text PubReader ePub PDF

Review Article

Current Update on Prostate Cancer Immunotherapy (4,822 times): Juliana E. Kim, Kunwoo Lee, Isaac Yi Kim; Journal of Urologic Oncology. 2023;21(1):14-22. Published online March 31, 2023; DOI: https://doi.org/10.22465/juo.234600100005
Cited By 2; Full text PubReader ePub PDF

Original Article

Bladder Preservation With Transurethral Tumor Resection and Intravesical BCG Instillation in Superficial Muscle-Invasive Bladder Cancer: A 10-Year Follow-up (4,141 times): Dong Gyun Kim, Ji Eun Heo, Kang Su Cho, Jongsoo Lee, Won Sik Jang, Nam Hoon Cho, Young Deuk Choi; Journal of Urologic Oncology. 2023;21(1):70-78. Published online March 31, 2023; DOI: https://doi.org/10.22465/juo.224400380019
Cited By 1; Full text PubReader ePub PDF

Invited Review

The Future of Adjuvant Therapy in Renal Cell Carcinoma: Recent Insights and Prospects (4,112 times): Hyerim Ha, Joo Han Lim; Journal of Urologic Oncology. 2023;21(3):208-216. Published online November 30, 2023; DOI: https://doi.org/10.22465/juo.234600540027
Cited By 1; Full text PubReader ePub PDF

The Landscape of Epidemiology in Urologic Cancers

Original Article

Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades (4,052 times): Sang Heon Han, Hyeong Dong Yuk; Journal of Urologic Oncology. 2023;21(1):32-44. Published online March 31, 2023; DOI: https://doi.org/10.22465/juo.234600080004
Cited By 12; Full text PubReader ePub PDF Supplementary Material

Bladder Cancer

Systemic Review and Meta-analysis

Poorer Outcomes in Bladder Cancer Patients With Diabetes: A Systematic Review and Meta-analysis Addressing Over 226,472 Bladder Cancer Patients (3,888 times): Stefani Frost, Parisa Ziarati, Ryan Moen, Lynn Kysh, Robert Johnson, Shane Pearce, Siamak Daneshmand, Kimberly D. Siegmund, Victoria K. Cortessis; Journal of Urologic Oncology. 2024;22(1):78-94. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600020001
Cited By 1; Full text PubReader ePub PDF Supplementary Material

Genetic Testing and Nonsurgical Management for Renal Cell Carcinoma

Invited Review

Genetic Testing for Prostate Cancer, Urothelial Cancer, and Kidney Cancer (3,844 times): Hyunho Han, Minyong Kang, Seok-Soo Byun, Seok Joong Yun; Journal of Urologic Oncology. 2023;21(2):128-139. Published online July 31, 2023; DOI: https://doi.org/10.22465/juo.234600340017
Cited By 1; Full text PubReader ePub PDF

Review Article

The Current State and Future of Plasma Cell-Free DNA Analysis in Urologic Malignancies (3,763 times): Shusuke Akamatsu, Kei Mizuno, Takayuki Sumiyoshi, Takayuki Goto, Takashi Kobayashi; Journal of Urologic Oncology. 2023;21(1):23-31. Published online March 31, 2023; DOI: https://doi.org/10.22465/juo.234600060003
Cited By 1; Full text PubReader ePub PDF

Trimodality Therapy and Immuno-Oncology for Bladder Cancer

Original Article

Radical Cystectomy Versus Bladder-Preserving Therapy in Muscle-Invasive Bladder Cancer Patients After Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Analysis (3,674 times): Youngheun Jo, Jun Seok Kim, Yoo Sub Shin, Jongchan Kim, Won Sik Jang, Jee Soo Park, Won Sik Ham; Journal of Urologic Oncology. 2023;21(2):165-173. Published online July 31, 2023; DOI: https://doi.org/10.22465/juo.234600280014
Cited By 1; Full text PubReader ePub PDF Supplementary Material

mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness

Original Article

A Cost-Benefit Comparison of Biparametric Magnetic Resonance Imaging Versus Conventional Prostate Cancer Screening (3,626 times): Jung Sik Huh, Kyung Kgi Park; Journal of Urologic Oncology. 2023;21(2):121-127. Published online July 31, 2023; DOI: https://doi.org/10.22465/juo.224400600030
Cited By 4; Full text PubReader ePub PDF

Trimodality Therapy and Immuno-Oncology for Bladder Cancer

Invited Review

The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials (3,614 times): Sang Hun Song, Jong Jin Oh; Journal of Urologic Oncology. 2023;21(2):154-164. Published online July 31, 2023; DOI: https://doi.org/10.22465/juo.234600300015
Cited By 4; Full text PubReader ePub PDF

Bladder Cancer

Invited Review

Nephron-Sparing Surgery for Upper Urinary Tract Urothelial Carcinoma (3,555 times): Sung Han Kim, Ilma S. Savul, Seth P. Lerner; Journal of Urologic Oncology. 2024;22(1):68-77. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600180009
Cited By 2; Full text PubReader ePub PDF

Prostate Cancer

Invited Review

Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review (3,495 times): Chang Wook Jeong; Journal of Urologic Oncology. 2024;22(1):4-10. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600220011
Cited By 5; Full text PubReader ePub PDF

mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness

Invited Review

The Role of Magnetic Resonance Imaging (MRI) and MRI-Targeted Biopsy for Active Surveillance (3,490 times): Chang Wook Jeong; Journal of Urologic Oncology. 2023;21(2):97-105. Published online July 31, 2023; DOI: https://doi.org/10.22465/juo.234600260013
Cited By 1; Full text PubReader ePub PDF

Original Article

The Prognostic Impact of Angiolymphatic Invasion in Bladder Urothelial Carcinoma Patients Undergoing Radical Cystectomy (3,430 times): Jin Hyuck Kim, Young Hwii Ko, Jong Wook Kim, Seok Ho Kang, Seung Il Jung, Jin Sung Park, Ho Kyung Seo, Hyung Joon Kim, Byong Chang Jeong, Tae-Hwan Kim, Se Young Choi, Jong Kil Nam, Ja Yoon Ku, Kwan Joong Joo, Won Sik Jang, Young Eun Yoon, Seok Joong Yun, Sung-Hoo Hong, Jong Jin Oh; Journal of Urologic Oncology. 2023;21(1):79-87. Published online March 31, 2023; DOI: https://doi.org/10.22465/juo.224400340017; Full text PubReader ePub PDF

Invited Review

Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use (3,322 times): Byung Kwan Park; Journal of Urologic Oncology. 2023;21(2):106-111. Published online July 31, 2023; DOI: https://doi.org/10.22465/juo.234600320016
Cited By 3; Full text PubReader ePub PDF

Original Article

Bladder Cancer in South Korea: Analysis of Trends and Risk Factors of Bladder Cancer in South Korea Using a Nationwide Database (3,196 times): Sangjun Yoo, Kyung-Do Han, Kwang Taek Kim, Woo Suk Choi, Yun-Sok Ha, Jeong Hyun Kim, Cheol Kwak; Journal of Urologic Oncology. 2023;21(1):45-52. Published online March 31, 2023; DOI: https://doi.org/10.22465/juo.234600040002
Cited By 2; Full text PubReader ePub PDF Supplementary Material

Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma

Invited Review

Influence of Body Composition on the Perioperative and Survival Outcomes of Renal Cell Carcinoma (3,096 times): Edouard H. Nicaise, Benjamin N. Schmeusser, Yash B. Shah, Mehmet A. Bilen, Kenneth Ogan, Viraj A. Master; Journal of Urologic Oncology. 2023;21(3):183-199. Published online November 30, 2023; DOI: https://doi.org/10.22465/juo.234600500025
Cited By 2; Full text PubReader ePub PDF

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043

MOST READ MOST CITED

7,510	Complex Epidemiology of Prostate Cancer in Asian Countries
5,560	Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023
5,091	Role of Radiotherapy in Metastatic Renal Cell Carcinomas: An Evolutionary Journey in a Misunderstood Histological Type
4,822	Current Update on Prostate Cancer Immunotherapy
4,141	Bladder Preservation With Transurethral Tumor Resection and Intravesical BCG Instillation in Superficial Muscle-Invasive Bladder Cancer: A 10-Year Follow-up

Cited By 12	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By 11	Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By 5	Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review
Cited By 5	Health Equity Research Outcomes and Improvement Consortium Prostate Cancer Health Precision Africa1K: Closing the Health Equity Gap Through Rural Community Inclusion
Cited By 4	A Cost-Benefit Comparison of Biparametric Magnetic Resonance Imaging Versus Conventional Prostate Cancer Screening

Editorial Office: Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817, FAX: +82-2-742-4665 Email: journal@e-juo.org

Korean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: leeseh@yuhs.ac

Copyright © The Korean Urological Oncology Society.